Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3
MAbs. 2026 Dec;18(1):2675077. doi: 10.1080/19420862.2026.2675077. Epub 2026 May 21.ABSTRACTDipeptidyl peptidase 3 (DPP3) is an intracellular protein involved in cellular antioxidant responses. Upon acute stress and tissue damage, DPP3 is released into the circulation (circulating DPP3, cDPP3), where

